https://www.has-sante.fr/jcms/p_3363305/fr/skyrizi-risankizumab-psoriasis-en-plaques-de-l-adulte 2022 France evaluation of the transparency committee skyrizi risankizumab risankizumab
--- https://www.has-sante.fr/jcms/p_3334262/fr/skyrizi-risankizumab-rhumatisme-psoriasique 2022 France evaluation of the transparency committee risankizumab skyrizi risankizumab